IGI Logo

Below the Quote June 2026 by Mr Jatin Gedia, Vice President – Technical Research at Teji Mandi

Nifty Pharma index has relatively outperformed the broader market over the last month, posting a positive return of ~1% while the majority of the other sectors showed negative returns. Looking at the YTD performance, the Pharma Index has returned ~7% and has been the second most rewarding sector during the volatile first half of calendar year 2026.  

Traditionally, FMCG and Pharma are considered safe havens during periods of volatility. Pharma sector has also benefited from the depreciating rupee which worked in its favour. Technically, most Pharma sector stocks have been in an uptrend and dips toward support levels are being bought. Our preferred picks among the Pharma names are Laurus Labs, Zydus Life, Glenmark Pharma, and Gland Pharma. 

Above views are of the author and not of the website kindly read disclaimer